Replies to post #1366 on BioLineRx Ltd (BLRX)

[midastouch017]

BLRX shares are deeply undervalued because having about 70c/share cash and no debt, the market is only assigning a value of about $30M to the company's extensive pipeline and rich collaboration deals.

[shub]

Hi Midas;
I wonder about BL 8040 and possible proliferations of side effects? It appears to affect some basic cellular functions and unless there's a way to tightly target it, it could wreak havoc.